< Back to previous page


Structure-based design of new antitubercular medicines

To goal of the CELSA alliance is to employ a structure centered approach to identify putative lead compounds that target aminoacyl-tRNA synthetases in Mycobacterium tuberculosis. The efforts would provide an important springboard for the future development of new antitubecular drugs.

Date:1 Oct 2017  →  30 Sep 2019
Disciplines:Microbiology, Systems biology, Laboratory medicine